Capecitabine in Metastatic Breast and GI Cancers
Public ClinicalTrials.gov record NCT02595320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.
Study identification
- NCT ID
- NCT02595320
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Qamar Khan
- Other
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Capecitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2015
- Primary completion
- Nov 30, 2022
- Completion
- Nov 30, 2023
- Last update posted
- Dec 19, 2021
2015 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 2
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Kansas Cancer Center - CRC | Fairway | Kansas | 66205 | — |
| St. Catherine Hospital - Central Care Cancer Center | Garden City | Kansas | 67846 | — |
| Heartland Cancer Center - Central Care Cancer Center | Great Bend | Kansas | 67530 | — |
| Hays Medical Center Dreiling-Schmidt Cancer Institute | Hays | Kansas | 67601 | — |
| University of Kansas Cancer Center - West | Kansas City | Kansas | 66112 | — |
| Olathe Medical Center | Olathe | Kansas | 66061 | — |
| University of Kansas Cancer Center - Overland Park | Overland Park | Kansas | 66210 | — |
| Via Christi Cancer Center | Pittsburg | Kansas | 66762 | — |
| Salina Regional Health | Salina | Kansas | 67401 | — |
| St. Francis Comprehensive Cancer Center | Topeka | Kansas | 66606 | — |
| University of Kansas Cancer Center - Westwood | Westwood | Kansas | 66205 | — |
| Truman Medical Center | Kansas City | Missouri | 64108 | — |
| University of Kansas Cancer Center - South | Kansas City | Missouri | 64131 | — |
| University of Kansas Cancer Center - North | Kansas City | Missouri | 64154 | — |
| University of Kansas Cancer Center - Lee's Summit | Lee's Summit | Missouri | 64064 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02595320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02595320 live on ClinicalTrials.gov.